Eclipse — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

Cellarescellares.com inApr 2021 · $257M

Cellares develops automated manufacturing systems and technology platforms to accelerate the production and commercialization of cell therapies.

Advanced ManufacturingBiotechMedical DevicesSouth San Francisco, US

Fabian Gerlinghaus(Co-Founder & CEO)inOmar Kurdi(Co-Founder & President)inAlex Pesch(Founder)Fabian Gerlinghaus Omar Kurdi(Founder)

BoardJustin Butler(Director)inVictor Tong(Director)in

Co-investorsDecheng Capital 8VC EcoR1 Capital Intuitive Ventures Koch Disruptive Technologies Baillie Gifford +4 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.